Phase III ROCKIES and OLYMPUS roxadustat trials
This announcement contains inside information 20 December 2018 07:00 GMT Phase III OLYMPUS and ROCKIES trials for roxadustat met their primary endpoints in chronic kidney disease patients with anaemia OLYMPUS demonstrated a statistically-significant and clinically-meaningful improvement in haemoglobin vs. placebo in non-dialysis-dependent patients ROCKIES demonstrated a statistically-significant improvement in haemoglobin vs. epoetin alfa in dialysis-dependent patients AstraZeneca today announced that the Phase III OLYMPUS and ROCKIES trials for roxadustat each met their